Jay E. Gold

591 total citations
21 papers, 418 citations indexed

About

Jay E. Gold is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Jay E. Gold has authored 21 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Immunology and 6 papers in Genetics. Recurrent topics in Jay E. Gold's work include CAR-T cell therapy research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (6 papers). Jay E. Gold is often cited by papers focused on CAR-T cell therapy research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (6 papers). Jay E. Gold collaborates with scholars based in United States. Jay E. Gold's co-authors include Ralph Zalusky, Amjad Khan, H. J. Ree, Michael E. Osband, S. Malamud, James A. Strauchen, Antonio Castella, V. S. Ghali, James P. Crowley and John M. Cosgrove and has published in prestigious journals such as Cancer, The American Journal of Medicine and International Journal of Cancer.

In The Last Decade

Jay E. Gold

21 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay E. Gold United States 13 235 151 89 73 67 21 418
Teresio Motta Italy 8 283 1.2× 244 1.6× 71 0.8× 35 0.5× 54 0.8× 11 394
H Oliva Spain 14 137 0.6× 222 1.5× 176 2.0× 53 0.7× 44 0.7× 54 559
Douglas W. Kingma United States 8 261 1.1× 372 2.5× 109 1.2× 112 1.5× 84 1.3× 10 551
Ziegler Jl United States 8 225 1.0× 173 1.1× 50 0.6× 44 0.6× 76 1.1× 24 436
P. Spaander Netherlands 10 108 0.5× 136 0.9× 27 0.3× 49 0.7× 44 0.7× 18 333
Sumie Tabata Japan 13 137 0.6× 141 0.9× 41 0.5× 113 1.5× 65 1.0× 49 449
Philippe Genet France 10 247 1.1× 118 0.8× 96 1.1× 34 0.5× 36 0.5× 44 536
Alessandra Viglio Italy 12 230 1.0× 216 1.4× 97 1.1× 37 0.5× 25 0.4× 28 478
G. Bellesi Italy 11 83 0.4× 172 1.1× 81 0.9× 78 1.1× 23 0.3× 16 336
Wu‐Ching Uen Taiwan 8 174 0.7× 137 0.9× 227 2.6× 96 1.3× 67 1.0× 10 502

Countries citing papers authored by Jay E. Gold

Since Specialization
Citations

This map shows the geographic impact of Jay E. Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay E. Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay E. Gold more than expected).

Fields of papers citing papers by Jay E. Gold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay E. Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay E. Gold. The network helps show where Jay E. Gold may publish in the future.

Co-authorship network of co-authors of Jay E. Gold

This figure shows the co-authorship network connecting the top 25 collaborators of Jay E. Gold. A scholar is included among the top collaborators of Jay E. Gold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay E. Gold. Jay E. Gold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gold, Jay E., Norman D. Bloom, Michail Shafir, et al.. (1995). Ex vivo activated memory t‐lymphocytes as adoptive cellular therapy of human soft‐tissue sarcoma targets with potentiation by Cis‐diamminedichloroplatinum (II). Journal of Surgical Oncology. 58(4). 212–221. 4 indexed citations
2.
Gold, Jay E., et al.. (1995). Adoptive transfer of ex vivo activated memory T-cells with or without cyclophosphamide for advanced metastatic melanoma: Results in 36 patients. European Journal of Cancer. 31(5). 698–708. 12 indexed citations
3.
Jaffer, Shabnam, et al.. (1995). Contralateral axillary lymph node metastasis as the first evidence of locally recurrent breast carcinoma. Cancer. 75(12). 2875–2878. 15 indexed citations
4.
5.
6.
Gold, Jay E., Ira J. Bleiweiss, Joel J. Bauer, et al.. (1994). Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis‐diamminedichloroplatinum(II). Journal of Surgical Oncology. 55(4). 222–228. 4 indexed citations
7.
Gold, Jay E., Michael E. Osband, & Robert J. Krane. (1994). Adoptive cellular therapy of urological neoplastic disease. Cancer Treatment Reviews. 20(2). 173–190. 2 indexed citations
8.
Gold, Jay E., et al.. (1993). Adoptive chemoimmunotherapy using Ex vivo activated memory T‐cells and cyclophosphamide: Tumor lysis syndrome of a metastatic soft tissue sarcoma. American Journal of Hematology. 44(1). 42–47. 29 indexed citations
9.
10.
Gold, Jay E., Ralph Zalusky, V. S. Ghali, et al.. (1992). T-cell chronic lymphocytic leukemia. Unusual morphologic, phenotypic, and karyotypic features in association with light chain amyloidosis. Cancer. 70(1). 86–93. 8 indexed citations
11.
12.
Vikram, Bhadrasain, S. Malamud, Jay E. Gold, et al.. (1991). Chemotherapy rapidly alternating with accelerated radiotherapy for advanced carcinomas of the hypopharynx and upper esophagus: A feasibility study. Head & Neck. 13(5). 415–419. 9 indexed citations
13.
Gold, Jay E., David Altarac, H. J. Ree, et al.. (1991). Hiv‐associated Hodgkin disease: A clinical study of 18 cases and review of the literature. American Journal of Hematology. 36(2). 93–98. 32 indexed citations
14.
15.
Gold, Jay E., V. S. Ghali, Scott Gold, John C. Brown, & Ralph Zalusky. (1990). Angiocentric immunoproliferative lesion/T-cell non-Hodgkin's lymphoma and the acquired immune deficiency syndrome: A case report and review of the literature. Cancer. 66(11). 2407–2413. 42 indexed citations
16.
Gold, Jay E., et al.. (1990). Malignant plasma cell tumors in human immunodeficiency virus-infected patients. Cancer. 66(2). 363–368. 36 indexed citations
17.
Gold, Jay E., Antonio Castella, & Ralph Zalusky. (1989). B‐cell acute lymphocytic leukemia in HIV‐antibody‐positive patients. American Journal of Hematology. 32(3). 200–204. 12 indexed citations
18.
Gold, Jay E., et al.. (1989). Hybrid acute leukemia in an HIV‐antibody‐positive patient. American Journal of Hematology. 30(4). 240–247. 13 indexed citations
19.
Gold, Jay E., et al.. (1988). Human immunodeficiency virus-related lymphoreticular malignancies and peripheral neurologic disease. A report of four cases. Cancer. 61(11). 2318–2324. 19 indexed citations
20.
Gold, Jay E.. (1978). Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.. PubMed. 3(1). 41–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teresio Motta Breakdown of academic impact, for papers by H Oliva Breakdown of academic impact, for papers by Douglas W. Kingma Breakdown of academic impact, for papers by Ziegler Jl Breakdown of academic impact, for papers by P. Spaander Breakdown of academic impact, for papers by Sumie Tabata Breakdown of academic impact, for papers by Philippe Genet Breakdown of academic impact, for papers by Alessandra Viglio Breakdown of academic impact, for papers by G. Bellesi Breakdown of academic impact, for papers by Wu‐Ching Uen
Rankless by CCL
2026